The HM-JACKarc system provides automated, rapid and consistent, high throughput Faecal Immunochemical Testing. See how it’s combination of innovative sampling device, assay technology and easy-to use platform ensure sensitive and
The HM-JACKarc FIT system employs an innovative sample collection device that is easy for patients to use and delivers a measured, stabilised sample for the laboratory, ready for direct loading
Your guide to the FIT bowel cancer screening test, from Cancer Research UK. FIT stands for faecal immunochemical test. It looks for tiny traces of blood in the poo which
In this video from RM Partners, Mr Nigel D’Souza, Colorectal Surgical Fellow, presents the results of the NICE FIT clinical trial. Find out more about the NICE FIT Study: https://www.nicefitstudy.com/
This Industry Sponsored Workshop entitled ‘FIT to Practice?’ was given by Professor Callum Fraser, Sally Benton and Nigel D’Souza. They discussed data collected from testing FIT in the Symptomatic since
Catch the interactive audience discussions from the workshop held at ACB Focus 2018 on the use of faecal immunochemical testing for detecting colorectal disease.
Dr David Burling describes the new colorectal diagnostic pathway being rolled out across west London. The pathway for patients on a 2ww urgent referral has been designed to enable them to
A guide supplied by Cancer Research UK to show users how to do the bowel cancer screening test in Scotland including how to collect the sample and what happens after
In this talk from the Digestive Diseases Day held on the 15th November 2017 in Birmingham, Professor Ramesh Arasaradnam, Consultant Gastroenterologist at University Hospital Coventry & Warwickshire, examines the patient
This presentation outlines the importance of safety-netting patients with a low faecal haemoglobin concentration, and modifying the current patient pathway to improve patient care. This was presented by Dr James
Sally Benton, Director, Bowel Cancer Screening Southern England Hub, outlines the significance of the newly published DG30, and provides guidance on its implementation. This presentation is from the Digestive Diseases
GP colonoscopy referrals can be cut by 40% by using FOBT as a test for ruling out symptomatic patients, pathologists have been told. The faecal immunochemical tests (FIT) currently used